Clinical trial
A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus…
NCT02722798 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT02722798 |
|---|---|
| Title | A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome |
| Official title | A Phase 2 Open-Label Trial to Assess the Efficacy and Safety of KRN23 in Patients With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome and a Post-marketing Study of KRN23 Switched From the Phase 2 Trial |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome |
| Intervention type | Drug |
| Interventions | KRN23 |
| Enrollment | 14 |
| Start date | Apr 1, 2016 |
| Primary completion | Jul 1, 2017 |
| Completion | Oct 1, 2020 |
| First posted | Mar 30, 2016 |
| Last update posted | Sep 6, 2022 |
| Countries | Japan, South Korea |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: